Assembly Biosciences, Inc. is a clinical-stage biotechnology company in the United States. The company is headquartered in South San Francisco, California.
| Revenue (TTM) | $71.10M |
| Gross Profit (TTM) | $6.24M |
| EBITDA | $-13.43M |
| Operating Margin | -138.40% |
| Return on Equity | -5.66% |
| Return on Assets | -5.06% |
| Revenue/Share (TTM) | $5.24 |
| Book Value | $12.50 |
| Price-to-Book | 2.25 |
| Price-to-Sales (TTM) | 6.33 |
| EV/Revenue | 3.128 |
| EV/EBITDA | 0.42 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -12.80% |
| Shares Outstanding | $19.82M |
| Float | $8.80M |
| % Insiders | 28.41% |
| % Institutions | 48.36% |
Volatility is currently contracting